94 related articles for article (PubMed ID: 15067565)
1. [BRCA1: from the gene identification to the cancer risk estimation].
Stoppa-Lyonnet D; Jeanpierre M
Med Sci (Paris); 2004 Mar; 20(3):262-3. PubMed ID: 15067565
[No Abstract] [Full Text] [Related]
2. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
3. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 cancer risks.
Antoniou AC; Pharoah PD; Easton DF; Evans DG
J Clin Oncol; 2006 Jul; 24(20):3312-3; author reply 3313-4. PubMed ID: 16829658
[No Abstract] [Full Text] [Related]
5. [Identification of cancer genes has made the testing of predisposition possible. Genetic counseling and mutation screening can result in new therapeutic methods].
Nordenskjöld M
Lakartidningen; 1999 Aug; 96(32-33):3392-6. PubMed ID: 10479788
[No Abstract] [Full Text] [Related]
6. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
7. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
[TBL] [Abstract][Full Text] [Related]
8. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition testing for breast cancer.
Schulman JD; Stern HJ
Cancer J Sci Am; 1996; 2(5):244-9. PubMed ID: 9166539
[No Abstract] [Full Text] [Related]
11. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing.
Gayther SA; Ponder BA
Mol Med Today; 1997 Apr; 3(4):168-74. PubMed ID: 9134530
[TBL] [Abstract][Full Text] [Related]
12. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
13. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
Hamann U
Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
[TBL] [Abstract][Full Text] [Related]
14. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
Loman N
Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
[TBL] [Abstract][Full Text] [Related]
15. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of BRCA1 genetic testing for Ashkenazi-Jewish women.
Wiesner GL
Health Matrix Clevel; 1997; 7(1):3-30. PubMed ID: 10167176
[No Abstract] [Full Text] [Related]
17. Legislation on genetic testing and the practice of oncology.
Surbone A
Crit Rev Oncol Hematol; 2009 Feb; 69(2):95-7. PubMed ID: 18993081
[No Abstract] [Full Text] [Related]
18. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
19. 18. Genetics of breast cancer.
Irving M; Elmslie F; Berg J
Int J Clin Pract; 2002 Nov; 56(9):677-82. PubMed ID: 12469982
[TBL] [Abstract][Full Text] [Related]
20. "First do no harm" also applies to cancer susceptibility testing.
Burke W; Kahn MJ; Garber JE; Collins FS
Cancer J Sci Am; 1996; 2(5):250-2. PubMed ID: 9166540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
